Company / Current Liabilities
Amgen Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$25.5B
FY2025
5-year range
$12.2B / $25.5B
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#6 of 215
Health Care
What the data says
Among 215 Health Care companies, Amgen is in the bottom 3% for current liabilities. Current Liabilities has increased for 5 consecutive years, from $11.7B in FY2020 to $25.5B in FY2025.
Based on SEC 10-K filings.
$25.5B in FY2025 with a 5-year CAGR of +16.9%. Top quartile in the Health Care sector.
Increased from $18.4B to $25.5B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 215This company $25.5B Sector average $1.6B
▼
+1518.4% above sector average
Key checks
Key Insights
- Amgen's current liabilities has grown for 5 consecutive years.
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2025, current liabilities increased 10.3% year-over-year.
- Ranks #6 out of 215 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.5B | +10.3% |
| FY2024 | $23.1B | +25.6% |
| FY2023 | $18.4B | +17.2% |
| FY2022 | $15.7B | +28.8% |
| FY2021 | $12.2B | +4.6% |
| FY2020 | $11.7B | -9.2% |
| FY2019 | $12.8B | -4.8% |
| FY2018 | $13.5B | +49.5% |
| FY2017 | $9.0B | -19.5% |
| FY2016 | $11.2B | +29.3% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026